睾酮假单胞菌3α-羟类固醇脱氢酶基因的质粒载体构建及表达

从土壤中分离睾酮假单胞菌,提取其基因组DNA,PCR扩增3α-羟类固醇脱氢酶（3α-hsd）基因,将扩增产物用NdeⅠ/BamHⅠ消化,切下目的基因片段克隆到质粒pET-15b中构建重组pET-15b.将重组pET-15b转化入E.coli DH5α中,经酶谱分析和测序,鉴定出正确的重组质粒pET-15b.将重组pET-15b转化入宿主菌E.coli BL21(DE3) pLysS中,用硫代半乳糖苷(IPTG)进行诱导表达.提取细菌总蛋白质进行SDS-聚丙烯酰胺凝胶电泳(PAGE)分析并测定酶活性.粗提物中酶活性高达2.45×10⁵ U/L.利用重组蛋白中的6个组氨酸(His)组成的“标签”进行亲和层析,经一步金属螯合亲和层析纯化后,重组蛋白在SDS-PAGE上呈现出均一的单一条带,回收率达68%.活性和纯度均较高的目的蛋白3α-HSD的获得,为血清总胆汁酸酶循环法测定奠定了基础.     

3β-羟基类固醇脱氢酶基因的克隆表达及其性质研究

目的:构建3β-羟基类固醇脱氢酶(3β-HSD)异源表达系统,进一步探究其酶学性质。方法:通过分子生物学方法克隆来源于Mycobacterium neoaurum菌株的3β-羟基类固醇基因,构建重组质粒,运用HPLC方法检测酶反应体系的产物。结果:本实验构建了表达载体pet28a-hsd。优化诱导表达条件,发现3β-HSD异源表达的最适温度为16℃~25℃,37℃时蛋白表达为包涵体。此外,同一温度下不同IPTG浓度诱导的表达结果差异不大。利用纯化后的蛋白进行酶特性的研究,结果表明在3β-HSD酶反应体系中,30℃达到较高的酶活性;pH 7.5~9.0之间,酶活力较强,pH低于7.0时,酶活性明显下降;有机助溶剂DMSO对酶反应有抑制作用;Fe~(3+)和Cu~(2+)对酶反应有抑制作用。结论:本实验探究了分枝杆菌中3β-羟基类固醇脱氢酶的相关性质,为进一步研究该酶在类固醇代谢中的功能提供基础。     

3α-羟类固醇脱氢酶的表达、纯化和酶学性质研究

从土壤中分离睾酮丛毛单胞菌,提取其基因组DNA,PCR扩增3α-羟类固醇脱氢酶（3α-HSD）基因。以质粒pET15b为载体,构建3α-HSD的原核表达系统。经IPTG诱导后,得到了具有酶活性的融合蛋白,细菌总蛋白的表达量为0.73g/L,其中融合酶蛋白占16.4%,活性达1.38×10.5U/L。利用融合蛋白N末端的Histag,经金属螯合亲和层析纯化后,得到了纯度较高的融合酶蛋白,酶蛋白的得率为68%,比活性为194.7U/mg。凝血酶切除Histag后,经质谱鉴定,重组蛋白的分子量为26.5kD,与理论推测值基本相同。25℃以雄酮为底物,以NAD+和thioNAD+为辅因子时,融合蛋白参与酶促反应的最适pH分别为10.5和9.4。37℃条件下酶促反应较快,25℃时的反应速度只有37℃时的52％,Q10（25℃～35℃）为1.7。25℃、pH105、以雄酮和各级胆汁酸为底物、NAD+为辅因子时,融合酶蛋白的动力学常数Km位于4.2～51.1μmol/L范围内。融合酶蛋白发挥催化作用并不需要金属离子的参与,而Fe3+、Fe2+、Zn2+则抑制酶活性,反应体系中加入EDTA也并不影响酶的活性。活性和纯度均较高的融合蛋白3α-HSD的获得及其生物学性质的研究,为血清总胆汁酸酶循环法测定的建立奠定了基础。     

番茄内质网ω-3脂肪酸去饱和酶基因原核表达载体的构建与鉴定

通过RT-PCR的方法从番茄叶片克隆到内质网ω-3脂肪酸去饱和酶(LeFAD3)基因的部分编码区,该片段cDNA为309 bp,将其克隆到pET-30a(+)载体中,酶切位点分别是BamH I和Sac I,构建了原核表达载体pET-LeFAD3,并在大肠杆菌BL21中表达融合蛋白,经IPTG诱导蛋白表达,提取蛋白并采用SDS-PAGE和蛋白质免疫印迹法检测目的蛋白的表达情况.酶切鉴定结果表明,LeFAD3基因原核表达载体构建成功,目的蛋白成功表达.     

全合成3α-羟类固醇脱氢酶基因密码子优化及酶性质研究

以NCBI报道的Comamonas testosteroni ATCC11996中3α-羟类固醇脱氢酶基因(3α-hydroxysteroid dehydrogenase gene,3α-hsd,AF092031.2)为模板,通过改变碱基序列但不影响酶的氨基酸序列,将该基因相对于大肠杆菌的密码子适用指数由0.78提高到0.87,GC含量由原来的63.17降低到56.46,大幅度减少了GC簇及寡聚A和T局域的存在,提高3α—hsd的可表达性。全合成基因定向克隆到pET28a载体中,并转化至大肠杆菌B121(DE3)中表达。采用乳糖诱导后,SDS—PAGE检测在约27 kD处有一高效表达的蛋白条带。采用Ni螯合柱分离纯化3α-HSD,获得了较高纯度及较高的产率。酶学性质初步分析表明,全基因合成表达的3α-HSD的性质与原始的3α-HSD基本相同。     

人IL-3基因原核表达载体的构建及表达

目的：构建人IL-3基因原核表达载体pET32a-IL-3,并在大肠杆菌中诱导表达。方法：通过佛波酯（TPA）和植物球血凝素（PHA）刺激人T淋巴细胞系Jurkat细胞,增加IL-3mRNA表达水平,提取mRNA,逆转录-聚合酶链反应（RT-PCR）获得cDNA,以Jurkat细胞cDNA为模板,通过PCR方法扩增得到人IL-3基因,将其克隆入原核表达载体pET32a（＋）中,将重组质粒转化入大肠杆菌宿主菌株BL21中,以异丙基硫代半乳糖苷（IPTG）诱导融合蛋白表达,并通过改变IPTG浓度,诱导时间,诱导温度等条件最终实现蛋白的可溶性表达。表达产物用SDS-PAGE检测表达情况。结果：酶切鉴定和测序结果证明成功构建了原核表达载体pET32a．IL-3。SDS-PAGE检测结果证明实现了人IL-3基因在大肠杆菌中的可溶性表达。结论：成功构建了人IL-3基因的原核表达载体并在大肠杆菌中获得了良好的表达。     

人IL-3基因原核表达载体的构建及表达

目的:构建人IL-3基因原核表达载体pET32a-IL-3,并在大肠杆菌中诱导表达。方法:通过佛波酯(TPA)和植物球血凝素(PHA)刺激人T淋巴细胞系Jurkat细胞,增加IL-3mRNA表达水平,提取mRNA,逆转录-聚合酶链反应(RT-PCR)获得cDNA,以Jurkat细胞cDNA为模板,通过PCR方法扩增得到人IL-3基因,将其克隆入原核表达载体pET32a(+)中,将重组质粒转化入大肠杆菌宿主菌株BL21中,以异丙基硫代半乳糖苷(IPTG)诱导融合蛋白表达,并通过改变IPTG浓度,诱导时间,诱导温度等条件最终实现蛋白的可溶性表达。表达产物用SDS-PAGE检测表达情况。结果:酶切鉴定和测序结果证明成功构建了原核表达载体pET32a-IL-3。SDS-PAGE检测结果证明实现了人IL-3基因在大肠杆菌中的可溶性表达。结论:成功构建了人IL-3基因的原核表达载体并在大肠杆菌中获得了良好的表达。     

人Hsp90α基因克隆、中试发酵及生物信息学分析

目的:克隆获得人热休克蛋白90α(Hsp90α)基因,构建其原核表达载体,分离纯化重组蛋白,为Hsp90抑制剂的体外筛选奠定基础.方法:TRIzol Reagent法提取K562细胞总RNA,通过RT-PCR获得Hsp90α-cDNA.以该cDNA为模板PCR扩增Hsp90α基因,目的基因和质粒pET28a(+)经Nco Ⅰ和Xho Ⅰ双酶切后,连接酶切片段,将重组DNA转化DH5α,酶切及测序鉴定重组体.将构建好的重组质粒转化Rosetta(DE3)菌株,IPTG诱导,经条件优化后进行中试发酵、纯化以及Western blot鉴定.结果:原核表达载体pET28a(+)-Hsp90α成功构建,可在Rosetta(DE3)中正确表达,中试发酵收菌574g且表达产物以可溶性形式存在,纯化产物纯度为97%.结论:利用分子克隆技术建立了Hsp90α基因的原核表达和中试发酵的条件,为更深入地研究其在抗肿瘤治疗中的作用打下基础.     

人趋化因子MIP-3α的原核可溶性表达及趋化活性分析

目的:克隆人趋化因子MIP3α,进行原核表达并初步鉴定其趋化活性。方法:从人扁桃体中提取总RNA,进行RTPCR,扩增MIP3α成熟蛋白基因,重组于pET32a( )载体,转化大肠杆菌BL21TrxB(DE3),进行融合表达,Westernblot验证融合蛋白,金属离子亲和层析,肠激酶酶切,弱阳离子交换层析,得到纯化的MIP3α蛋白,趋化试验鉴定其趋化活性。结果:成功构建了MIP3α天然蛋白的硫氧还蛋白融合表达载体,表达并纯化出MIP3α蛋白,Westernblot证明融合蛋白能与羊抗人MIP3α抗体结合,纯化的MIP3α蛋白能趋化HEK293CCR6稳定转染细胞。结论:构建的天然MIP3α融合表达载体以可溶性蛋白的方式稳定表达MIP3α,初步纯化得到的MIP3α具有趋化HEK293CCR6稳定转染细胞的活性。     

人抑癌基因PTEN的原核表达载体的构建及融合表达

为研究抑癌因子PTEN蛋白的抑癌机理,掏建了PTEN cDNA的原核表达载体并进行融合表达。将含有PTEN cDNA的质粒pMD-PTEN经EcoR Ⅰ和Sal Ⅰ双酶切,回收PTEN基因片段与经相同酶切的高效原核表达载体pET-44a连接,经序列测定,证实融合型表达载体pET-Nus-PTEN构建成功。转化表达宿主BL21(DE3)后,IPTG诱导表达。经12％SDS-PAGE凝胶电泳,获得118kD的特异蛋白条带。目的蛋白占细菌总蛋白的17％。结果表明：PTEN基因和Nus基因融合表达成功,获得可溶性Nus-PTEN蛋白。该研究为PTEN蛋白的抑癌机理和基因工程药物的研究打下了基础,这是国内PTEN蛋白在原核细胞中成功表达的首次报道。     

大肠埃希菌Mn-SOD基因的克隆、表达及多克隆抗体制备

目的实现Mn-SOD基因在大肠埃希菌中的高可溶性表达,制备Mn-SOD的多克隆抗体。方法用PCR方法从一株野生型大肠埃希菌（E.coli）基因组中扩增Mn-SOD基因编码区．将它克隆到原核表达载体上进行大量表达和纯化,再用纯化的蛋白对新西兰大白兔进行背部多点注射,40d后取其血清,用Western-blot印迹实验测定抗体效果。结果SDS-PAGE分析表明SOD的表达量约为细菌总蛋白的50％;黄嘌呤氧化酶法测定表达蛋白活性,结果表明每毫克菌体可溶性总蛋白中表达产物酶比活为3921．77U／mg,是对照BL21的276．77倍;并制备了高效价的多克隆抗体。结论该研究成功地构建了大肠埃希菌Mn-SOD基因高效原核表达系统,所表达的Mn-SOD具有良好的免疫原性和免疫反应性。     

Ovarian and placental expression of 20α-hydroxysteroid dehydrogenase during pregnancy in deer

The enzyme 20α-hydroxysteroid dehydrogenase (20α-HSD) catalyzes the conversion of progesterone to its inactive form, 20α-hydroxyprogesterone. This enzyme has been shown to play a critical role in the regulation of luteal function in experimental animals. In this study, we cloned and expressed the gene encoding elk deer 20α-HSD from reproductive placental and ovarian tissues. PCR, 3'- and 5'-RACE, and northern blot analysis were performed for the cloning and characterization of deer 20α-HSD gene. We expressed recombinant deer 20α-HSD protein and used western blot analysis to determine protein expression levels in the placenta and ovary during pregnancy. The full cDNA sequence of 20α-HSD was used to clone an open reading frame encoding 323 amino acids and consisting of 1142 bp. The nucleotide sequence of deer 20α-HSD showed high homology with the sequences of the bovine (96%), goat (96%), and human (83%) 20α-HSD genes. 20α-HSD mRNA was strongly expressed in the placenta on days 30, 60, and 70 of pregnancy. A high level of the protein was also detected in the placenta but not in fetal skin tissue. The recombinant 20α-HSD protein produced in mammalian cells and bacterial systems had a molecular weight of approximately 37-kDa. The deer 20α-HSD protein signal was specifically localized in the basal part of the primary chorionic villi and chorionic stem villus of the placenta during early pregnancy. The 20α-HSD protein was also intensively localized in the larger luteal cells of the corpus luteum during pregnancy.     

鼠李糖乳杆菌D-(+)-乳酸脱氢酶基因的克隆及在大肠杆菌中的表达

利用PCR的方法从鼠李糖乳杆菌基因组DNA中扩增到D-(+)-乳酸脱氢酶基因(ldhD),并连接到载体pSE380上,构建表达质粒pSE-ldhD,将重组质粒pSE-ldhD转化大肠杆菌BL21(DE3),重组菌株经IPTG诱导表达,SDS-PAGE电泳分析表明ldhD在大肠杆菌中实现了表达,表达产物的分子量约为37kD。同时采用紫外分光光度法测定D-乳酸脱氢酶的酶活,测得重组菌株的D-乳酸脱氢酶活力为5.4U/mL,最适反应温度为35℃,最适pH为5.6。     

Molecular cloning of rat liver 3α-hydroxysteroid dehydrogenase and identification of structurally related proteins from rat lung and kidney

3α-Hydroxysteroid dehydrogenase and related enzymes play important roles in the metabolism of endogenous compounds including androgens, corticosteroid, prostaglandins and bile acids, as well as drugs and xenobiotics such as benzo(a)pyrene. Complementary DNA clones encoding 3α-hydroxysteroid dehydrogenase were isolated from a rat liver cDNA lambda gt11 expression library using monoclonal antibodies as probes. A full-length cDNA clone of 1286 base pairs contained an open reading frame encoding a protein of 322 amino acids with an estimated M(w) of 37 kD. When expressed in E. coli, the encoded protein migrated to the same position on SDS-polycrylamide gels as the enzyme in rat liver cytosols. The protein expressed in bacteria was highly active in androsterone oxidation in the presence of NAD as cofactor and this activity was inhibited by indomethacin, a potent inhibitor of 3α-hydroxysteroid dehydrogenase. The predicted amino acid sequence of 3α-hydroxysteroid d dehydrogenase was related to sequences of several other aldo-keto reductases such as bovine prostaglandin F synthase, human chlordecone reductase, human aldose reductase, human aldehyde reductase and frog lens epsilon-crystallin, suggesting that these proteins belong to the same gene family. Recently, we have found that monoclonal antibodies against 3α-hydroxysteroid dehydrogenase also recognized multiple antigenically related proteins in rat lung, kidney and testis. Further screening of liver, lung and kidney cDNA libraries using these monoclonal antibodies as probes resulted in the isolation of additional five different cDNAs encoding proteins with high degree of structural homology to rat liver 3α-hydroxysteroid dehydrogenase.     

酮古龙酸菌山梨醇脱氢酶的原核表达及活性检测

目的：克隆酮古龙酸菌Y25的山梨醇脱氢酶基因sldh,在大肠杆菌中进行表达并检测表达产物的活性。方法：以酮古龙酸菌Y25基因组DNA为模板,PCR扩增sldh基因,连接到表达载体pTIG,转入大肠杆菌BL21（DE3）,IPTG诱导表达;取表达菌体、菌体裂解上清和沉淀进行SDS-PAGE分析;以山梨醇为底物,通过活性电泳、体外转化及休止细胞转化进行sldh基因表达产物的活性检测。结果：扩增得到1740 bp的山梨醇脱氢酶基因,构建了表达质粒pTIG-sldh并在大肠杆菌中获得表达,SDS-PAGE结果显示表达产物为可溶性形式,相对分子质量约58×10^3;活性电泳结果说明表达产物在以山梨醇为底物时表现出脱氢酶活性,而经体外转化和休止细胞转化后薄层层析检测出转化产物山梨糖的存在。结论：在大肠杆菌中实现了酮古龙酸菌山梨醇脱氢酶的可溶性表达,且表达的重组脱氢酶能将山梨醇脱氢生成山梨糖。     

棉铃虫核型多角体病毒sod基因在大肠杆菌中的表达

用PCR方法从棉铃虫(Helicoverpa armigera)单粒包埋型核型多角体病毒(HaSNPV) C1株基因组中扩增sod基因编码区,克隆到pGEM—T—easy vector,测定了核苷酸序列。将基因编码区克隆到原核表达载体pETblue2,构建了含表达质粒pETblue2／HaSNPV SOD,转化大肠杆菌DE3 (BL21)进行IPTG诱导表达。SDS—PAGE分析表明SOD的表达量约为细胞总蛋白的37％。邻苯三酚法测定表达蛋白活性,结果表明每毫克菌体可溶性总蛋白中表达产物校正酶活力单位为694U／mg。     

植原体免疫主导膜蛋白Imp基因原核表达载体构建及表达

旨在构建植原体免疫主导膜蛋白Imp基因原核表达载体,并进行初步表达。以重组克隆质粒pMD18-T-Imp为模板,PCR扩增Imp基因片段。构建表达载体pET-28a(+)-Imp,转化宿主菌E.coliBL21(DE3)。筛选阳性克隆,提取重组质粒作PCR鉴定、酶切鉴定及IPTG诱导表达鉴定。PCR及双酶切结果显示,重组质粒pET-28a(+)-Imp构建成功。经IPTG诱导BL21(pET-28a(+)-Imp)表达约20 kD的蛋白,与预期的携带6×His-Tag的目的蛋白(19.5 kD)大小相符,主要以包涵体形式存在。结果显示,构建的表达载体pET-28a(+)-Imp在E.coliBL21(DE3)中能够达一定量表达,为进一步纯化Imp蛋白奠定基础。     

内生多粘类芽胞杆菌纤溶酶基因PPFE-I在大肠杆菌中融合表达及活性分析

以内生多粘类芽胞杆菌EJS-3基因组DNA为模板,PCR扩增PPFE-I基因,并克隆到pMD19-T载体上,构建克隆载体pMD-PPFE-I,经测序正确后,将PPFE-I基因克隆至表达载体pET-DsbA上构建重组表达质粒pET-DsbA/PPFE-I,将其转化至E. coli BL21(DE3),在IPTG诱导下实现了融合蛋白DsbA-PPFE-I的表达,表达产物酶活性达228 IU/mL。表达产物用SDS-PAGE和Western blotting进行鉴定。SDS-PAGE电泳检测表明融合蛋白主要以可溶形式表达,占菌体总蛋白的18.4％。Western blotting结果表明在相应分子量处有一条特异性条带,证实该蛋白为DsbA-PPFE-I融合蛋白。表达产物通过Ni亲和柱、凝血酶酶切及Sephadex G-100等步骤进行分离纯化,并用 MALDI-TOF 质谱对重组酶进行了鉴定。纯化后的表达产物在纤维蛋白平板上表现出明显的纤溶活性。     

乙内酰脲水解酶基因在大肠杆菌中的克隆表达

节杆菌BT801的乙内酰脲酶系能够水解5-苄基乙内酰脲生成L-苯丙氨酸,其中乙内酰脲水解酶负责乙内酰脲的水解开环。乙内酰脲水解酶的表达对于乙内酰脲酶的催化机制研究及氨基酸的生物不对称合成都具有重要意义。通过PCR技术扩增得到乙内酰脲水解酶基因(hyuH),置于表达载体pT221的,17启动子下游,将构建的重组质粒引入大肠杆菌BL21(DE3)。SDS-PAGE分析在相对分子量50kD处有一较强的表达带,经薄层扫描分析目的蛋白占全菌蛋白的40％,主要以可溶性形式存在,活性分析表明表达产物具有天然的酶活性。     

Cloning and expression of cDNA encoding hamster liver 3-hydroxyhexobarbital/17β(3α)-hydroxysteroid dehydrogenase 1

Using RACE techniques we have cloned and sequenced one of the hamster liver 3-hydroxy-hexobarbital dehydrogenases which catalyze not only cyclic alcohols but also 17β-hydroxy-steroids and 3α-hydroxysteroids. The gene specific primers to 3-hydroxyhexobarbital dehydrogenase 1 (G2) were synthesized on the basis of its partial peptide sequences. The sequence of full length cDNA generated by 3′- and 5′-RACE PCR consisted of 1225 nucleotides including an open reading frame of 972 nucleotides encoding a protein of 323 amino acids. The deduced amino acid sequence matched exactly with the partial peptide sequences of hamster liver 3-hydroxyhexobarbital dehydrogenase 1 (G2). The sequence showed 84.5% identity to mouse liver 17β-dehydrogenase(A-specific), and 74–76% identity to human liver bile acid binding protein/3α-hydroxysteroid dehydrogenase (DD2), human liver 3α-hydroxysteroid dehydrogenase type I (DD4) and type II (DD3), and rabbit ovary 20α-hydroxysteroid dehydrogenase. The protein contains catalytic residues of aldo-keto reductases, Asp50, Tyr55, Lys84, His117. These results suggest that the hamster liver 3-hydroxyhexobarbital/17β(3α)-hydroxysteroid dehydrogenase belongs to aldo-keto reductase superfamily. The insert containing the full-length cDNA of 3-hydroxyhexobarbital dehydrogenase and vector specific overhang produced by PCR was annealed with pET-32 Xa/LIC vector. The plasmid was transformed into BL21 (DE3) cells containing pLysS. The recombinant enzyme was induced 1 mM IPTG. The expressed enzyme was produced as fusion protein and purified by nickel chelating affinity chromatography followed by POROS CM column chromatography and superdex 75 gel filtration. Molecular weight of the recombinant enzyme fused thioredoxin and his•tag was about 55 000 and that was 35 000 after Factor Xa protease treatment. The recombinant enzyme dehydrogenated 3-hydroxy-hexobarbital, 1-acenaphthenol, 2-cyclohexen-1-ol, testosterone, glycolithocholic acid as well as the native enzyme purified from hamster liver.